New tools for epilepsy therapy

C Falcicchia, M Simonato, G Verlengia

Research output: Contribution to journalArticlepeer-review


One third of the epilepsies are refractory to conventional antiepileptic drugs (AEDs) and, therefore, identification of new therapies is highly needed. Here, we briefly describe two approaches, direct cell grafting and gene therapy, that may represent alternatives to conventional drugs for the treatment of focal epilepsies. In addition, we discuss more in detail some new tools, cell based-biodelivery systems (encapsulated cell biodelivery (ECB) devices) and new generation gene therapy vectors, which may help in the progress toward clinical translation. The field is advancing rapidly, and there is optimism that cell and/or gene therapy strategies will soon be ready for testing in drug-resistant epileptic patients. © 2018 Falcicchia, Simonato and Verlengia.
Original languageEnglish
Article number147
JournalFrontiers in Cellular Neuroscience
Publication statusPublished - 2018


Dive into the research topics of 'New tools for epilepsy therapy'. Together they form a unique fingerprint.

Cite this